As shown in Figure 4C and 4D, treatment with phloroglucinol led to a significant reduction in the number of CD31+ capillary microvessels in the peritumoral region, suggesting that phloroglucinol might suppress tumor-induced angiogenesis in vivo. Here, PECAM1 is linked to neoplasm.